ClinicalTrials.Veeva

Menu

Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy

E

Englewood Hospital and Medical Center

Status

Enrolling

Conditions

Liver Cancer Adult
Liver Regeneration

Treatments

Other: carbon monoxide measurement via smokerlyzer

Study type

Interventional

Funder types

Other

Identifiers

NCT06681818
E-24-982

Details and patient eligibility

About

the investigators will pursue two specific aims: (1) to monitor the extent of heme oxygenase induction (by measuring endogenous CO production) in relationship to the extent of hepatic resection (2) to assess the production of CO in patients following liver resection and correlate these findings to the rate of liver regeneration and liver function.

Enrollment

125 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient plans to have partial liver resection for primary liver pathology or metastatic disease
  • Patient is able to comprehend and willing to sign the written consent form

Exclusion criteria

  • Patients < 18 years
  • Patients identified as members of a vulnerable population, except women of child bearing potential with negative pregnancy test

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

125 participants in 1 patient group

all participants
Experimental group
Description:
all participants will provide breath samples to detect carbon monoxide levels
Treatment:
Other: carbon monoxide measurement via smokerlyzer

Trial contacts and locations

1

Loading...

Central trial contact

Jamie Ketas; Raquel Molina

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems